NCT01728636View on ClinicalTrials.gov

The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 15, 2013

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
Curvature of Spine
Interventions
DRUG

Tranexamic Acid

intravenous administration of bolus and infusion for duration of surgical procedure

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01728636 - The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery | Biotech Hunter | Biotech Hunter